Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gastric Cancer

  Free Subscription


Articles published in Eur J Surg Oncol

Retrieve available abstracts of 68 articles:
HTML format
Text format



Single Articles


    April 2017
  1. MILONE M, Elmore U, Musella M, Parise P, et al
    Safety and efficacy of laparoscopic wedge gastrectomy for large gastrointestinal stromal tumors.
    Eur J Surg Oncol. 2017;43:796-800.
    PubMed     Text format     Abstract available


  2. KESHAVA HB, Rosen JE, DeLuzio MR, Kim AW, et al
    "What if I do nothing?" The natural history of operable cancer of the alimentary tract.
    Eur J Surg Oncol. 2017;43:788-795.
    PubMed     Text format     Abstract available


    March 2017
  3. BOULIARIS K, Rachiotis G, Diamantis A, Christodoulidis G, et al
    Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system.
    Eur J Surg Oncol. 2017 Mar 27. pii: S0748-7983(17)30430.
    PubMed     Text format     Abstract available


  4. SASAKO M
    Is there role for laparoscopic gastrectomy for advanced gastric cancer.
    Eur J Surg Oncol. 2017 Mar 8. pii: S0748-7983(17)30363.
    PubMed     Text format    


  5. CHOI YY, Cheong JH
    Beyond precision surgery: Molecularly motivated precision care for gastric cancer.
    Eur J Surg Oncol. 2017 Mar 1. pii: S0748-7983(17)30360.
    PubMed     Text format     Abstract available


    February 2017
  6. NORERO E, Vega EA, Diaz C, Cavada G, et al
    Improvement in postoperative mortality in elective gastrectomy for gastric cancer: Analysis of predictive factors in 1066 patients from a single centre.
    Eur J Surg Oncol. 2017 Feb 10. pii: S0748-7983(17)30050.
    PubMed     Text format     Abstract available


  7. CLIMENT M, Munarriz M, Blazeby JM, Dorcaratto D, et al
    Weight loss and quality of life in patients surviving 2 years after gastric cancer resection.
    Eur J Surg Oncol. 2017 Feb 9. pii: S0748-7983(17)30337.
    PubMed     Text format     Abstract available


  8. BOURAS G, Markar SR, Burns EM, Huddy JR, et al
    The psychological impact of symptoms related to esophagogastric cancer resection presenting in primary care: A national linked database study.
    Eur J Surg Oncol. 2017;43:454-460.
    PubMed     Text format     Abstract available


    January 2017
  9. KAITO A, Kinoshita T, Shitara K, Shibasaki H, et al
    Timing of initiation of adjuvant chemotherapy for gastric cancer: A case-matched comparison study of laparoscopic vs. open surgery.
    Eur J Surg Oncol. 2017 Jan 29. pii: S0748-7983(17)30058.
    PubMed     Text format     Abstract available


  10. LEHMANN K, Eshmuminov D, Bauerfeind P, Gubler C, et al
    18FDG-PET-CT improves specificity of preoperative lymph-node staging in patients with intestinal but not diffuse-type esophagogastric adenocarcinoma.
    Eur J Surg Oncol. 2017;43:196-202.
    PubMed     Text format     Abstract available


  11. KIM S, Paget-Bailly S, Messager M, Nguyen T, et al
    Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma.
    Eur J Surg Oncol. 2017;43:218-225.
    PubMed     Text format     Abstract available


  12. PARRY K, van Rossum PS, Haj Mohammad N, Ruurda JP, et al
    The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis.
    Eur J Surg Oncol. 2017;43:226-233.
    PubMed     Text format     Abstract available


    December 2016
  13. TU RH, Lin JX, Zheng CH, Li P, et al
    Development of a nomogram for predicting the risk of anastomotic leakage after a gastrectomy for gastric cancer.
    Eur J Surg Oncol. 2016 Dec 20. pii: S0748-7983(16)31052.
    PubMed     Text format     Abstract available


  14. PARK JM, Kim HI, Han SU, Yang HK, et al
    Who may benefit from robotic gastrectomy?: A subgroup analysis of multicenter prospective comparative study data on robotic versus laparoscopic gastrectomy.
    Eur J Surg Oncol. 2016;42:1944-1949.
    PubMed     Text format     Abstract available


    October 2016
  15. XIE JW, Sun YQ, Feng CY, Zheng CH, et al
    Evaluation of clinicopathological factors related to the prognosis of gastric neuroendocrine carcinoma.
    Eur J Surg Oncol. 2016;42:1464-70.
    PubMed     Text format     Abstract available


  16. MOSQUERA C, Koutlas NJ, Fitzgerald TL
    Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance.
    Eur J Surg Oncol. 2016;42:1471-7.
    PubMed     Text format     Abstract available


    September 2016
  17. LEE JH, Kang JW, Nam BH, Cho GS, et al
    Correlation between lymph node count and survival and a reappraisal of lymph node ratio as a predictor of survival in gastric cancer: A multi-institutional cohort study.
    Eur J Surg Oncol. 2016 Sep 30. pii: S0748-7983(16)30895.
    PubMed     Text format     Abstract available


  18. LOU N, Chi CH, Chen XD, Zhou CJ, et al
    Sarcopenia in overweight and obese patients is a predictive factor for postoperative complication in gastric cancer: A prospective study.
    Eur J Surg Oncol. 2016 Sep 17. pii: S0748-7983(16)30894.
    PubMed     Text format     Abstract available


  19. MESSAGER M, de Steur W, Boelens PG, Jensen LS, et al
    Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group - European Registration of Cancer Care).
    Eur J Surg Oncol. 2016;42:1432-47.
    PubMed     Text format     Abstract available


    August 2016
  20. KOMATSU S, Ichikawa D, Nishimura M, Kosuga T, et al
    Evaluation of prognostic value and stage migration effect using positive lymph node ratio in gastric cancer.
    Eur J Surg Oncol. 2016 Aug 21. pii: S0748-7983(16)30839.
    PubMed     Text format     Abstract available


  21. WU HT, Li Y
    Reply to: Re: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center, Eur J Surg Oncol (2016).
    Eur J Surg Oncol. 2016 Aug 12. pii: S0748-7983(16)30638.
    PubMed     Text format    


  22. MARANO L, Marrelli D, Roviello F
    Focus on research: Nodal dissection for gastric cancer - A dilemma worthy of King Solomon!
    Eur J Surg Oncol. 2016 Aug 11. pii: S0748-7983(16)30838.
    PubMed     Text format    


  23. KIM JW, Choi SH
    Re: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center, Eur J Surg Oncol (2016).
    Eur J Surg Oncol. 2016 Aug 11. pii: S0748-7983(16)30639.
    PubMed     Text format    


  24. MAKUUCHI R, Sugisawa N, Kaji S, Hikage M, et al
    Enhanced recovery after surgery for gastric cancer and an assessment of preoperative carbohydrate loading.
    Eur J Surg Oncol. 2016 Aug 10. pii: S0748-7983(16)30834.
    PubMed     Text format     Abstract available


  25. CAPELLI L, Petracci E, Quagliuolo V, Saragoni L, et al
    Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study.
    Eur J Surg Oncol. 2016;42:1206-14.
    PubMed     Text format     Abstract available


  26. KULIG P, Sierzega M, Pach R, Kolodziejczyk P, et al
    Differences in prognosis of Siewert II and III oesophagogastric junction cancers are determined by the baseline tumour staging but not its anatomical location.
    Eur J Surg Oncol. 2016;42:1215-21.
    PubMed     Text format     Abstract available


  27. O'NEILL AC, Shinagare AB, Kurra V, Tirumani SH, et al
    Assessment of metastatic risk of gastric GIST based on treatment-naive CT features.
    Eur J Surg Oncol. 2016;42:1222-8.
    PubMed     Text format     Abstract available


    July 2016
  28. RAMOS RF, Scalon FM, Scalon MM, Dias DI, et al
    Staging laparoscopy in gastric cancer to detect peritoneal metastases: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2016 Jul 9. pii: S0748-7983(16)30633.
    PubMed     Text format     Abstract available


    June 2016
  29. RAUSEI S, Ruspi L, Rosa F, Morgagni P, et al
    Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study.
    Eur J Surg Oncol. 2016 Jun 1. pii: S0748-7983(16)30153.
    PubMed     Text format     Abstract available


  30. YANG Y, Gao P, Song Y, Sun J, et al
    The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: A meta-analysis.
    Eur J Surg Oncol. 2016 Jun 1. pii: S0748-7983(16)30180.
    PubMed     Text format     Abstract available


    May 2016
  31. WU HT, Peng KW, Ji ZH, Sun JH, et al
    Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center.
    Eur J Surg Oncol. 2016 May 3. pii: S0748-7983(16)30114.
    PubMed     Text format     Abstract available


    April 2016
  32. TIBERIO GA, Ministrini S, Gardini A, Marrelli D, et al
    Factors influencing survival after hepatectomy for metastases from gastric cancer.
    Eur J Surg Oncol. 2016 Apr 19. pii: S0748-7983(16)30047.
    PubMed     Text format     Abstract available


  33. COCCOLINI F, Catena F, Glehen O, Yonemura Y, et al
    Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer. Systematic review and meta-analysis.
    Eur J Surg Oncol. 2016 Apr 19. pii: S0748-7983(16)30053.
    PubMed     Text format     Abstract available


  34. YONEMURA Y, Canbay E, Li Y, Coccolini F, et al
    A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent.
    Eur J Surg Oncol. 2016 Apr 9. pii: S0748-7983(16)30025.
    PubMed     Text format     Abstract available


    March 2016
  35. KOIZUMI N, Harada Y, Beika M, Minamikawa T, et al
    Highly sensitive fluorescence detection of metastatic lymph nodes of gastric cancer with photo-oxidation of protoporphyrin IX.
    Eur J Surg Oncol. 2016 Mar 31. pii: S0748-7983(16)00381.
    PubMed     Text format     Abstract available


  36. YAMASHITA K, Hosoda K, Ema A, Watanabe M, et al
    Lymph node ratio as a novel and simple prognostic factor in advanced gastric cancer.
    Eur J Surg Oncol. 2016 Mar 15. pii: S0748-7983(16)00379.
    PubMed     Text format     Abstract available


  37. PARRY K, Haverkamp L, Bruijnen RC, Siersema PD, et al
    Staging of adenocarcinoma of the gastroesophageal junction.
    Eur J Surg Oncol. 2016;42:400-6.
    PubMed     Text format     Abstract available


    January 2016
  38. MORITA S, Fukagawa T, Fujiwara H, Katai H, et al
    The clinical significance of para-aortic nodal dissection for advanced gastric cancer.
    Eur J Surg Oncol. 2016 Jan 26. pii: S0748-7983(16)00044.
    PubMed     Text format     Abstract available


    December 2015
  39. ZHOU CJ, Chen FF, Zhuang CL, Pang WY, et al
    Feasibility of radical gastrectomy for elderly patients with gastric cancer.
    Eur J Surg Oncol. 2015 Dec 6. pii: S0748-7983(15)00894.
    PubMed     Text format     Abstract available


    November 2015
  40. MARANO L, Polom K, Patriti A, Roviello G, et al
    Surgical management of advanced gastric cancer: An evolving issue.
    Eur J Surg Oncol. 2015 Nov 14. pii: S0748-7983(15)00840.
    PubMed     Text format     Abstract available


    October 2015
  41. NORERO E, Bustos M, Herrera ME, Cerda J, et al
    Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
    Eur J Surg Oncol. 2015 Oct 24. pii: S0748-7983(15)00825.
    PubMed     Text format     Abstract available


  42. HAVERKAMP L, Ruurda JP, Offerhaus GJ, Weijs TJ, et al
    Laparoscopic gastrectomy in Western European patients with advanced gastric cancer.
    Eur J Surg Oncol. 2015 Oct 22. pii: S0748-7983(15)00793.
    PubMed     Text format     Abstract available


  43. GLATZ T, Bronsert P, Schafer M, Kulemann B, et al
    Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome.
    Eur J Surg Oncol. 2015;41:1300-7.
    PubMed     Text format     Abstract available


  44. MINE S, Kurokawa Y, Takeuchi H, Kishi K, et al
    Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
    Eur J Surg Oncol. 2015;41:1348-53.
    PubMed     Text format     Abstract available


    September 2015
  45. MESSAGER M, de Steur WO, van Sandick JW, Reynolds J, et al
    Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre).
    Eur J Surg Oncol. 2015 Sep 30. pii: S0748-7983(15)00792.
    PubMed     Text format     Abstract available


  46. CLIMENT M, Hidalgo N, Vidal O, Puig S, et al
    Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer.
    Eur J Surg Oncol. 2015 Sep 3. pii: S0748-7983(15)00735.
    PubMed     Text format     Abstract available


  47. BARCHI LC, Yagi OK, Jacob CE, Mucerino DR, et al
    Predicting recurrence after curative resection for gastric cancer: External validation of the Italian Research Group for Gastric Cancer (GIRCG) prognostic scoring system.
    Eur J Surg Oncol. 2015 Sep 3. pii: S0748-7983(15)00736.
    PubMed     Text format     Abstract available


    July 2015
  48. YAMASHITA K, Ushiku H, Katada N, Hosoda K, et al
    Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
    Eur J Surg Oncol. 2015 Jul 29. pii: S0748-7983(15)00479.
    PubMed     Text format     Abstract available



  49. Retraction notice to "Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: An updated meta-analysis of randomized controlled trials" [Eur J Surg Oncol 40 (10) (October 2014) 1321-1330].
    Eur J Surg Oncol. 2015;41:953.
    PubMed     Text format    


  50. GOH BK, Goh YC, Eng AK, Chan WH, et al
    Outcome after laparoscopic versus open wedge resection for suspected gastric gastrointestinal stromal tumors: A matched-pair case-control study.
    Eur J Surg Oncol. 2015;41:905-10.
    PubMed     Text format     Abstract available


    June 2015
  51. WANG Y, Shen C, Ge J, Duan H, et al
    Regular aspirin use and stomach cancer risk in China.
    Eur J Surg Oncol. 2015;41:801-4.
    PubMed     Text format     Abstract available


    May 2015
  52. SCHMIDT T, Alldinger I, Blank S, Klose J, et al
    Surgery in oesophago-gastric cancer with metastatic disease: Treatment, prognosis and preoperative patient selection.
    Eur J Surg Oncol. 2015 May 29. pii: S0748-7983(15)00436.
    PubMed     Text format     Abstract available


  53. KINOSHITA J, Fushida S, Tsukada T, Oyama K, et al
    Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.
    Eur J Surg Oncol. 2015 May 15. pii: S0748-7983(15)00429.
    PubMed     Text format     Abstract available


  54. YAMAGUCHI H, Kitayama J, Emoto S, Ishigami H, et al
    Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
    Eur J Surg Oncol. 2015 May 8. pii: S0748-7983(15)00415.
    PubMed     Text format     Abstract available


    April 2015
  55. COCCOLINI F, Catena F, Glehen O, Yonemura Y, et al
    Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis.
    Eur J Surg Oncol. 2015 Apr 14. pii: S0748-7983(15)00366.
    PubMed     Text format     Abstract available


  56. BIONDI A, D'Ugo D, Cananzi FC, Papa V, et al
    Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer?
    Eur J Surg Oncol. 2015 Apr 8. pii: S0748-7983(15)00362.
    PubMed     Text format     Abstract available


  57. NAMIKAWA T, Fukudome I, Ogawa M, Munekage E, et al
    Clinical efficacy of protein-bound polysaccharide K in patients with gastric cancer undergoing chemotherapy with an oral fluoropyrimidine (S-1).
    Eur J Surg Oncol. 2015 Apr 3. pii: S0748-7983(15)00356.
    PubMed     Text format     Abstract available


  58. WU XJ, Miao RL, Li ZY, Bu ZD, et al
    Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer.
    Eur J Surg Oncol. 2015 Apr 3. pii: S0748-7983(15)00360.
    PubMed     Text format     Abstract available


    March 2015
  59. KUMAGAI K, Rouvelas I, Tsai JA, Mariosa D, et al
    Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer: a direct and adjusted indirect comparison meta-analysis.
    Eur J Surg Oncol. 2015;41:282-94.
    PubMed     Text format     Abstract available


    February 2015
  60. FERNANDES E, Coratti A, Lombardi A, Di Marino M, et al
    Robot-assisted surgery for gastric carcinoma: Five years follow-up and beyond: A single western center experience and long-term oncological outcomes.
    Eur J Surg Oncol. 2015 Feb 23. pii: S0748-7983(15)00026.
    PubMed     Text format     Abstract available


  61. SUN ZC, Xu WG, Xiao XM, Yu WH, et al
    Ultrasonic dissection versus conventional electrocautery during gastrectomy for gastric cancer: A meta-analysis of randomized controlled trials.
    Eur J Surg Oncol. 2015 Feb 4. pii: S0748-7983(15)00058.
    PubMed     Text format     Abstract available


  62. DE MANZONI G, Verlato G, Bencivenga M, Marrelli D, et al
    Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer.
    Eur J Surg Oncol. 2015 Feb 4. pii: S0748-7983(15)00056.
    PubMed     Text format     Abstract available


    January 2015
  63. MARANO L, Roviello F
    The distinctive nature of HER2-positive gastric cancers.
    Eur J Surg Oncol. 2015 Jan 10. pii: S0748-7983(15)00003.
    PubMed     Text format    


    December 2014
  64. JIANG N, Deng JY, Ding XW, Liu Y, et al
    Tumor volume as a prognostic factor was superior to the seventh edition of the pT classification in resectable gastric cancer.
    Eur J Surg Oncol. 2014 Dec 9. pii: S0748-7983(14)01266.
    PubMed     Text format     Abstract available


  65. PIESSEN G, Messager M, Lefevre JH, Goere D, et al
    Signet ring cell adenocarcinomas: different clinical-pathological characteristics of oesophageal and gastric locations.
    Eur J Surg Oncol. 2014;40:1746-55.
    PubMed     Text format     Abstract available


    November 2014
  66. TAN BH, Brammer K, Randhawa N, Welch NT, et al
    Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer.
    Eur J Surg Oncol. 2014 Nov 26. pii: S0748-7983(14)01258.
    PubMed     Text format     Abstract available


  67. KIM DH, Choi MG, Noh JH, Sohn TS, et al
    Clinical significance of skip lymph node metastasis in gastric cancer patients.
    Eur J Surg Oncol. 2014 Nov 11. pii: S0748-7983(14)01137.
    PubMed     Text format     Abstract available


    October 2014
  68. JACK S, West MA, Raw D, Marwood S, et al
    The effect of neoadjuvant chemotherapy on physical fitness and survival in patients undergoing oesophagogastric cancer surgery.
    Eur J Surg Oncol. 2014;40:1313-20.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: